AI Bias Analysis
4 models · Takes ~15 seconds
(MedPage Today) -- Revolution Medicines announced that its investigational RAS inhibitor daraxonrasib doubled median overall survival for previously treated advanced pancreatic cancer (13.2 vs 6.7 months) in a randomized phase III trial comparing...
Source
MedPage Today
Opens original article in a new tab
(MedPage Today) -- Lower hemoglobin levels were associated with progressively higher dementia risk and elevated blood concentrations of Alzheimer's disease biomarkers, data from a Swedish cohort study suggested. In a study of 2,300 older adults...
(MedPage Today) -- HHS Secretary Robert F. Kennedy Jr.'s positions on mercury contaminants, HHS personnel cuts, raw milk, and other controversies were front and center at a House hearing on Thursday. Rep. Josh Harder (D-Calif.) said that the Environmental...
(MedPage Today) -- A Venezuelan man pleaded his case to asylum officials on Thursday in an interview that his wife, a well-known emergency physician in South Texas, planned to attend until she was detained at the airport with the couple's 5-year...
(MedPage Today) -- The balance between risk and benefit with low-dose aspirin after an episode of giant cell arteritis (GCA) remains murky, according to a French population-based retrospective cohort study. Patients with a first hospitalization...
